A NEW Alzheimer's drug has been approved in the US amid growing calls for the NHS to improve early diagnosis so Brits can benefit from the treatment.
UK regulators are still reviewing Donanemab, the world's first disease-modifying treatments for dementia, approved by the US Food and Drug Administration on Tuesday.
This story is from the July 04, 2024 edition of Daily Record.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the July 04, 2024 edition of Daily Record.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Any one of us can get the boot
Thelin keeps Shinnie on toes before 13 bid
IT'S NOT MY CALL TO AXE ERIK
Ratcliffe refusing to back under-fire boss
SIGHT SAVER
Woman could have lost eye if treatment had been delayed
I TRIED
Secret Service agent's regrets over the assassination of JFK
CRASH OAP ROBBED BY HEALTH WORKER
Nursing assistant dodges jail over callous theft
MEAL FIT FOR A KING
THE chance to dine like the King at Balmoral Castle has sold out within days.
Stella loses right to roam home fight
McCartney £5m mansion privacy blow
LORD LUCAN: THE NANNY'S STORY
Builder who lost mum hunts peer 50 years on
Sir Jackie's £4m to dementia research
SIR Jackie Stewart has announced £4.2million worth of funding to help find a cure for dementia.
A sorry excuse
Unrepentant Johnson says he regrets apologising for parties